Correlation Between Altamira Therapeutics and Landos Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Altamira Therapeutics and Landos Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altamira Therapeutics and Landos Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altamira Therapeutics and Landos Biopharma, you can compare the effects of market volatilities on Altamira Therapeutics and Landos Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altamira Therapeutics with a short position of Landos Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altamira Therapeutics and Landos Biopharma.

Diversification Opportunities for Altamira Therapeutics and Landos Biopharma

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Altamira and Landos is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Altamira Therapeutics and Landos Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Landos Biopharma and Altamira Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altamira Therapeutics are associated (or correlated) with Landos Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Landos Biopharma has no effect on the direction of Altamira Therapeutics i.e., Altamira Therapeutics and Landos Biopharma go up and down completely randomly.

Pair Corralation between Altamira Therapeutics and Landos Biopharma

If you would invest  402.00  in Landos Biopharma on August 28, 2024 and sell it today you would earn a total of  0.00  from holding Landos Biopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy2.33%
ValuesDaily Returns

Altamira Therapeutics  vs.  Landos Biopharma

 Performance 
       Timeline  
Altamira Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Landos Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Landos Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Landos Biopharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Altamira Therapeutics and Landos Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Altamira Therapeutics and Landos Biopharma

The main advantage of trading using opposite Altamira Therapeutics and Landos Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altamira Therapeutics position performs unexpectedly, Landos Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will offset losses from the drop in Landos Biopharma's long position.
The idea behind Altamira Therapeutics and Landos Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years